Pancreatic cancer pill shown to nearly double overall survival time, drug company says

Pancreatic cancer pill shown to nearly double overall survival time, drug company says

The company reports the drug showed “clinically meaningful improvements” in overall survival.

Original Source

Read the full article at Thehill →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.